Estradiol Completed Phase 4 Trials for Postmenopausal Disorder / Urination Disorders / Urinary Bladder, Overactive Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01833663Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women